Cliff Asness's IBRX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 222,862 shares of ImmunityBio, Inc. (IBRX) worth $1.95 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in IBRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 156,315 shares. Largest reduction occurred in Q4 2025, reducing 57,154 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ImmunityBio (IBRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly ImmunityBio (IBRX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +156,315 | Add 234.89% | 222,862 | $8.76 |
| Q1 2026 | +19,922 | Add 42.73% | 66,547 | $7.67 |
| Q4 2025 | -57,154 | Reduce 55.07% | 46,625 | $1.98 |
| Q3 2025 | -55,383 | Reduce 34.80% | 103,779 | $2.46 |
| Q2 2025 | +114,714 | Add 258.09% | 159,162 | $2.64 |
| Q1 2025 | +29,297 | Add 193.37% | 44,448 | $3.01 |
| Q4 2024 | -39,736 | Reduce 72.40% | 15,151 | $2.56 |
| Q3 2024 | +6,435 | Add 13.28% | 54,887 | $3.72 |
| Q2 2024 | +29,727 | Add 158.76% | 48,452 | $6.32 |
| Q1 2024 | +18,725 | New Buy | 18,725 | $5.37 |
Cliff Asness's ImmunityBio Investment FAQs
Cliff Asness first purchased ImmunityBio, Inc. (IBRX) in Q1 2024, acquiring 18,725 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ImmunityBio, Inc. (IBRX) for 10 quarters since Q1 2024.
Cliff Asness's largest addition to ImmunityBio, Inc. (IBRX) was in Q2 2026, adding 222,862 shares worth $1.95 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 222,862 shares of ImmunityBio, Inc. (IBRX), valued at approximately $1.95 M.
As of the Q2 2026 filing, ImmunityBio, Inc. (IBRX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in ImmunityBio, Inc. (IBRX) was 222,862 shares, as reported at the end of Q2 2026.